Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Dyadic International Inc DYAI

Healthcare Biotechnology
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica ... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:DYAI)

Dyadic Reports 2023 Full Year Results and Recent Company Progress

GlobeNewswire March 28, 2024

Dyadic Announces Change in Board and Management Leadership Roles

GlobeNewswire March 28, 2024

Dyadic to Attend Industry Events in April

GlobeNewswire March 27, 2024

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

GlobeNewswire March 26, 2024

Dyadic to Attend Future Food Tech Event March 21 - 22, 2024 in San Francisco, California

GlobeNewswire March 21, 2024

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

GlobeNewswire March 14, 2024

CORRECTION - Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

GlobeNewswire March 11, 2024

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

GlobeNewswire March 11, 2024

Dyadic to Attend Industry Events in March

GlobeNewswire March 1, 2024
View More News ››

Opinion & Analysis (NDAQ:DYAI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:DYAI)

Dyadic Announces Change in Board and Management Leadership

JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ...
AveragePenny - March 28, 2024

Dyadic to Attend Industry Events in April

JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global...
AveragePenny - March 27, 2024

Dyadic Announces Publication of C1 Monoclonal Antibody...

The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman...
AveragePenny - March 26, 2024

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024

JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global...
AveragePenny - March 21, 2024

Dyadic to Report Full Year 2023 Financial Results and Host

JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ...
averagepennies - March 15, 2024

Dyadic Announces Closing of Private Placement of $6.0 M

JUNIPER, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ...
averagepennies - March 11, 2024
View more Bullboard ››

Etruscus Resources Corp.

Etruscus Resources Corp.

Etruscus Resources is a precious and critical metals exploration company focused on the development of two properties that ...
View More »